These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11965856)

  • 1. [Tumor markers in breast neoplasm].
    Coronato S; Laguens GE; Spinelli OM; Di Girolamo W
    Medicina (B Aires); 2002; 62(1):73-82. PubMed ID: 11965856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generation of molecular prognostic and predictive tests for breast cancer.
    Pusztai L; Cristofanilli M; Paik S
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers in the diagnosis and staging of breast cancer.
    Dillon DA
    Semin Radiat Oncol; 2002 Oct; 12(4):305-18. PubMed ID: 12382189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteome analysis for identification of tumor-associated biomarkers in breast cancer].
    Wang X; Liang WJ; Zhu ZY; Yang MT; Zeng YX
    Ai Zheng; 2004 Nov; 23(11 Suppl):1577-81. PubMed ID: 15566683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.
    Rock CL; Flatt SW; Natarajan L; Thomson CA; Bardwell WA; Newman VA; Hollenbach KA; Jones L; Caan BJ; Pierce JP
    J Clin Oncol; 2005 Sep; 23(27):6631-8. PubMed ID: 16170170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic aspects of bladder cancer.
    Kim WJ; Quan C
    J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
    Chong YM; Subramanian A; Sharma AK; Mokbel K
    Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research and the changing face of breast cancer.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S1-2. PubMed ID: 15597214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.
    Ambrogi F; Biganzoli E; Querzoli P; Ferretti S; Boracchi P; Alberti S; Marubini E; Nenci I
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):781-90. PubMed ID: 16467089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions.
    Sneige N
    Diagn Cytopathol; 2004 Mar; 30(3):158-65. PubMed ID: 14986295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving decision-making in early breast cancer: who to treat and how?
    Llombart-Cussac A
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.